NuCana (NCNA) Beginning Cash Balance (2017 - 2024)
NuCana (NCNA) reported Beginning Cash Balance of $21.9 million for Q1 2024, down 57.11% on a YoY basis from $50.9 million in Q2 2023, and down 57.11% sequentially from $50.9 million in Q1 2023.
NuCana (NCNA) Beginning Cash Balance (2017 - 2024) Analysis & Trends
NuCana (NCNA) has 8 years of Beginning Cash Balance data on file, last reported at $21.9 million in Q1 2024.
- For the quarter ending Q1 2024, Beginning Cash Balance fell 57.11% year-over-year to $21.9 million; the trailing twelve-month figure through Dec 2024 stood at $21.9 million (changed N/A YoY), and the FY2025 full-year result was $8.9 million, down 59.59% from the prior year.
- Beginning Cash Balance slipped to $21.9 million in Q1 2024, from $50.9 million in the prior quarter.
- In the past five years, Beginning Cash Balance ranged from a high of $120.5 million in Q1 2021 to a low of $21.9 million in Q1 2024.
- A 5-year average of $68.1 million and a median of $66.6 million in 2020 frame the typical range for Beginning Cash Balance.
- Across the five-year window, Beginning Cash Balance soared 80.84% in 2021 and slumped 57.11% in 2024, its largest moves.
- Tracing NCNA's Beginning Cash Balance over 5 years: stood at $66.6 million in 2020, then soared by 80.84% to $120.5 million in 2021, then sank by 32.87% to $80.9 million in 2022, then sank by 37.0% to $50.9 million in 2023, then tumbled by 57.11% to $21.9 million in 2024.
- Business Quant data shows NCNA's Beginning Cash Balance at $21.9 million in Q1 2024, $50.9 million in Q1 2023, and $80.9 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 21.85 Mn |
| Mar 31, 2024 | 21.85 Mn |
| Mar 31, 2023 | 50.94 Mn |
| Mar 31, 2023 | 50.94 Mn |
| Mar 31, 2022 | 80.86 Mn |
| Mar 31, 2022 | 80.86 Mn |
| Mar 31, 2021 | 120.46 Mn |
| Mar 31, 2021 | 120.46 Mn |
| Mar 31, 2020 | 66.61 Mn |
| Mar 31, 2020 | 66.61 Mn |
| Mar 31, 2019 | 100.21 Mn |
| Mar 31, 2019 | 100.21 Mn |
| Mar 31, 2018 | 120.61 Mn |
| Mar 31, 2018 | 120.61 Mn |
| Mar 31, 2017 | 24.76 Mn |
| Mar 31, 2017 | 24.76 Mn |